Clicky

Comera Life Sciences Holdings, Inc.(CMRA)

Description: Leading a compassionate new era in medicine, Comera Life Sciences is applying a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The goal of this approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen.


Keywords: Injection Orphan Drug

Home Page: comeralifesciences.com

CMRA Technical Analysis

12 Gill Street
Woburn, MA 01801
United States
Phone: 617 871 2101


Officers

Name Title
Mr. Jeffrey S. Hackman Chairman, Pres & CEO
Dr. David Soane Ph.D. Co-Founder & Member of Scientific Advisory Board
Dr. Neal I. Muni M.D., MSPH Exec. VP & COO
Dr. Robert P. Mahoney Ph.D. Chief Scientific Officer
Mr. Michael G. Campbell CPA Exec. VP & CFO
Ms. Janice Marie McCourt B.S., CLP, M.B.A., R.Ph. Chief Bus. Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 43.2823
IPO Date: 2022-05-19
Fiscal Year End: December
Full Time Employees: 11
Back to stocks